Literature DB >> 29769339

Differential Responses by Human Respiratory Epithelial Cell Lines to Respiratory Syncytial Virus Reflect Distinct Patterns of Infection Control.

Philippa Hillyer1, Rachel Shepard2, Megan Uehling2, Mina Krenz2, Faruk Sheikh3, Kalyn R Thayer2, Lei Huang4, Lihan Yan4, Debasis Panda2, Cindy Luongo5, Ursula J Buchholz5, Peter L Collins5, Raymond P Donnelly3, Ronald L Rabin2.   

Abstract

Respiratory syncytial virus (RSV) infects small foci of respiratory epithelial cells via infected droplets. Infection induces expression of type I and III interferons (IFNs) and proinflammatory cytokines, the balance of which may restrict viral replication and affect disease severity. We explored this balance by infecting two respiratory epithelial cell lines with low doses of recombinant RSV expressing green fluorescent protein (rgRSV). A549 cells were highly permissive, whereas BEAS-2B cells restricted infection to individual cells or small foci. After infection, A549 cells expressed higher levels of IFN-β-, IFN-λ-, and NF-κB-inducible proinflammatory cytokines. In contrast, BEAS-2B cells expressed higher levels of antiviral interferon-stimulated genes, pattern recognition receptors, and other signaling intermediaries constitutively and after infection. Transcriptome analysis revealed that constitutive expression of antiviral and proinflammatory genes predicted responses by each cell line. These two cell lines provide a model for elucidating critical mediators of local control of viral infection in respiratory epithelial cells.IMPORTANCE Airway epithelium is both the primary target of and the first defense against respiratory syncytial virus (RSV). Whether RSV replicates and spreads to adjacent epithelial cells depends on the quality of their innate immune responses. A549 and BEAS-2B are alveolar and bronchial epithelial cell lines, respectively, that are often used to study RSV infection. We show that A549 cells are permissive to RSV infection and express genes characteristic of a proinflammatory response. In contrast, BEAS-2B cells restrict infection and express genes characteristic of an antiviral response associated with expression of type I and III interferons. Transcriptome analysis of constitutive gene expression revealed patterns that may predict the response of each cell line to infection. This study suggests that restrictive and permissive cell lines may provide a model for identifying critical mediators of local control of infection and stresses the importance of the constitutive antiviral state for the response to viral challenge. This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.

Entities:  

Keywords:  cytokine; cytokines; interferon; interferon regulatory factor (IRF); interferon-stimulated genes; interferons; respiratory epithelial cells; respiratory syncytial virus

Mesh:

Substances:

Year:  2018        PMID: 29769339      PMCID: PMC6052282          DOI: 10.1128/JVI.02202-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  The acetyltransferase HAT1 moderates the NF-κB response by regulating the transcription factor PLZF.

Authors:  Anthony J Sadler; Bandar A Suliman; Liang Yu; Xiangliang Yuan; Die Wang; Aaron T Irving; Soroush T Sarvestani; Ashish Banerjee; Ashley S Mansell; Jun-Ping Liu; Steve Gerondakis; Bryan R G Williams; Dakang Xu
Journal:  Nat Commun       Date:  2015-04-13       Impact factor: 14.919

2.  Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells.

Authors:  Ping Liu; Mohammad Jamaluddin; Kui Li; Roberto P Garofalo; Antonella Casola; Allan R Brasier
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

3.  Partial Attenuation of Respiratory Syncytial Virus with a Deletion of a Small Hydrophobic Gene Is Associated with Elevated Interleukin-1β Responses.

Authors:  Ryan F Russell; Jacqueline U McDonald; Maria Ivanova; Ziyun Zhong; Alexander Bukreyev; John S Tregoning
Journal:  J Virol       Date:  2015-06-17       Impact factor: 5.103

4.  RSV replication is attenuated by counteracting expression of the suppressor of cytokine signaling (SOCS) molecules.

Authors:  Koichi Hashimoto; Kei Ishibashi; Ken Ishioka; Dongchi Zhao; Masatoki Sato; Shinichiro Ohara; Yusaku Abe; Yukihiko Kawasaki; Yuka Sato; Shin-Ichi Yokota; Nobuhiro Fujii; Ray Stokes Peebles; Mitsuaki Hosoya; Tatsuo Suzutani
Journal:  Virology       Date:  2009-07-12       Impact factor: 3.616

5.  The Interleukin-13 Receptor-α1 Chain Is Essential for Induction of the Alternative Macrophage Activation Pathway by IL-13 but Not IL-4.

Authors:  Faruk Sheikh; Harold Dickensheets; Joao Pedras-Vasconcelos; Thirumalai Ramalingam; Laura Helming; Siamon Gordon; Raymond P Donnelly
Journal:  J Innate Immun       Date:  2015-03-07       Impact factor: 7.349

6.  Sustained activation of interferon regulatory factor 3 during infection by paramyxoviruses requires MDA5.

Authors:  Nathalie Grandvaux; Xiaochun Guan; Fabrice Yoboua; Nicolas Zucchini; Karin Fink; Priscilla Doyon; Lydie Martin; Marc J Servant; Stéfany Chartier
Journal:  J Innate Immun       Date:  2014-04-30       Impact factor: 7.349

7.  Respiratory syncytial virus replication in human lung epithelial cells: inhibition by tumor necrosis factor alpha and interferon beta.

Authors:  R Merolla; N A Rebert; P T Tsiviste; S P Hoffmann; J R Panuska
Journal:  Am J Respir Crit Care Med       Date:  1995-10       Impact factor: 21.405

8.  Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genes.

Authors:  Stéphane Biacchesi; Mario H Skiadopoulos; Kim C Tran; Brian R Murphy; Peter L Collins; Ursula J Buchholz
Journal:  Virology       Date:  2004-04-10       Impact factor: 3.616

9.  Expression profiles of human interferon-alpha and interferon-lambda subtypes are ligand- and cell-dependent.

Authors:  Philippa Hillyer; Viraj P Mane; Lynnsie M Schramm; Montserrat Puig; Daniela Verthelyi; Aaron Chen; Zeng Zhao; Maria B Navarro; Kevin D Kirschman; Srikant Bykadi; Ronald G Jubin; Ronald L Rabin
Journal:  Immunol Cell Biol       Date:  2012-01-17       Impact factor: 5.126

10.  Suppression of interferon lambda signaling by SOCS-1 results in their excessive production during influenza virus infection.

Authors:  Haitao Wei; Song Wang; Qinghuang Chen; Yuhai Chen; Xiaojuan Chi; Lianfeng Zhang; Shile Huang; George F Gao; Ji-Long Chen
Journal:  PLoS Pathog       Date:  2014-01-02       Impact factor: 6.823

View more
  24 in total

1.  Differential interferon gene expression in bronchiolitis caused by respiratory syncytial virus-A genotype ON1.

Authors:  Alessandra Pierangeli; Agnese Viscido; Camilla Bitossi; Federica Frasca; Massimo Gentile; Giuseppe Oliveto; Antonella Frassanito; Raffaella Nenna; Fabio Midulla; Carolina Scagnolari
Journal:  Med Microbiol Immunol       Date:  2019-09-04       Impact factor: 3.402

2.  Mycoplasma pneumoniae Compared to Streptococcus pneumoniae Avoids Induction of Proinflammatory Epithelial Cell Responses despite Robustly Inducing TLR2 Signaling.

Authors:  R C A de Groot; H Zhu; T Hoogenboezem; A C J M de Bruijn; E Eenjes; A E J 't Jong; A I Belo; S C Estevão; J J Bajramovic; R J Rottier; M Kool; A M C van Rossum; W W J Unger
Journal:  Infect Immun       Date:  2022-07-11       Impact factor: 3.609

3.  Respiratory syncytial virus activates Rab5a to suppress IRF1-dependent IFN-λ production, subverting the antiviral defense of airway epithelial cells.

Authors:  Shi Mo; Wei Tang; Jun Xie; Sisi Chen; Luo Ren; Na Zang; Xiaohong Xie; Yu Deng; Leiqiong Gao; Enmei Liu
Journal:  J Virol       Date:  2021-01-27       Impact factor: 6.549

Review 4.  Contribution of Cytokines to Tissue Damage During Human Respiratory Syncytial Virus Infection.

Authors:  Karen Bohmwald; Nicolás M S Gálvez; Gisela Canedo-Marroquín; Magdalena S Pizarro-Ortega; Catalina Andrade-Parra; Felipe Gómez-Santander; Alexis M Kalergis
Journal:  Front Immunol       Date:  2019-03-18       Impact factor: 7.561

Review 5.  Prevention of Pediatric Respiratory Syncytial Virus Lower Respiratory Tract Illness: Perspectives for the Next Decade.

Authors:  Sofia S Aranda; Fernando P Polack
Journal:  Front Immunol       Date:  2019-05-07       Impact factor: 7.561

Review 6.  Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity.

Authors:  Diego R Hijano; Luan D Vu; Lawrence M Kauvar; Ralph A Tripp; Fernando P Polack; Stephania A Cormier
Journal:  Front Immunol       Date:  2019-03-26       Impact factor: 7.561

Review 7.  Airway Epithelial Derived Cytokines and Chemokines and Their Role in the Immune Response to Respiratory Syncytial Virus Infection.

Authors:  Lena Glaser; Patricia J Coulter; Michael Shields; Olivier Touzelet; Ultan F Power; Lindsay Broadbent
Journal:  Pathogens       Date:  2019-07-19

8.  Toxicity of Water- and Organic-Soluble Wood Tar Fractions from Biomass Burning in Lung Epithelial Cells.

Authors:  Michal Pardo; Chunlin Li; Zheng Fang; Smadar Levin-Zaidman; Nili Dezorella; Hendryk Czech; Patrick Martens; Uwe Käfer; Thomas Gröger; Christopher P Rüger; Lukas Friederici; Ralf Zimmermann; Yinon Rudich
Journal:  Chem Res Toxicol       Date:  2021-05-25       Impact factor: 3.739

9.  Comparative Transcriptomic Analysis of Rhinovirus and Influenza Virus Infection.

Authors:  Thrimendra Kaushika Dissanayake; Sascha Schäuble; Mohammad Hassan Mirhakkak; Wai-Lan Wu; Anthony Chin-Ki Ng; Cyril C Y Yip; Albert García López; Thomas Wolf; Man-Lung Yeung; Kwok-Hung Chan; Kwok-Yung Yuen; Gianni Panagiotou; Kelvin Kai-Wang To
Journal:  Front Microbiol       Date:  2020-07-21       Impact factor: 5.640

Review 10.  Innate Immune Components that Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections.

Authors:  Catalina A Andrade; Gaspar A Pacheco; Nicolas M S Gálvez; Jorge A Soto; Susan M Bueno; Alexis M Kalergis
Journal:  Viruses       Date:  2020-06-12       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.